TNFAIP3 and neoplasm: The results showed that, si-A20 significantly decreased the percentages of Tregs in tumors, from 4.82% to 2.29% (p < 0.05), which suggested an improved immune response at tumor site after si-A20 treatment (Fig. 4c).